Health Care: Drugs

Isis Pharmaceuticals (ISIS: NASDAQ)

$30.83 0.52 | 1.72%
07/11/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 30.31
52 Week High 62.66
52 Week Low 22.25
Avg. Daily Vol. (Mil) 2.92
Beta (3 year) 1.65
Share Related Items
Mkt Cap (Mil) 3,563.77
Shares Out (Mil) 117.58
Float (Mil) 99.75
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.40
Current Ratio 7.20
LT Debt/ Equity 0.61
Total Debt / Equity 0.62
Valuation Ratios
Price Earnings n.a.
Price/Sales 26.98
Price/Book 9.53
Price/Cash Flow -65.50
Per Share Data
Earnings -0.79
Sales 1.12
Book Value 3.18
Cash Flow -0.46
Business Summary
Isis Pharmaceuticals is engaged in antisense drug discovery and development, exploiting a novel drug discovery platform it created to generate a broad pipeline of first-in-class drugs.
General Information
2855 Gazelle Court
Carlsbad, CA 92010
www.isispharm.com
Industry : Drugs
Sector: Health Care
Employees: 365
CEO: Dr. Stanley T. Crooke,M.
Short Interest
Current Month (Mil) 13.41
Previous Month (Mil) 12.52
Short Interest Ratio (Days) 4.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -10.80
Return on Investments -15.00
Profitability
Gross Margin n.a.
EBIT Margin -86.80
Profit Margin -68.30

Portfolios with ISIS

Latest ISIS Headlines from TheStreet

More Financial News for ISIS

Press Releases for ISIS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter